Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
Business Wire•04/11/2026•06:35 ET
0
Key Highlights
- ➤Cencora realigns reporting into Specialty Pharmaceutical and Provider Services and Pharmaceutical Distribution and Services segments
- ➤Richard Tremonte will lead Cencora’s combined specialty businesses
- ➤Remaining U.S. businesses organized into Health Systems and Retail Pharmacy and Alternate Care verticals
- ➤Cencora will recast fiscal 2025 and 2026 unaudited segment financial information in Form 8-K
Expert Statements
Robert P. Mauch, President and Chief Executive Officer of Cencora
“Over the last two years, Cencora has taken significant steps to advance our strategy through investments to further our leadership in specialty and enhance our service to our customers and partners. Our realigned organizational structure reflects our focus on ensuring Cencora is uniquely positioned as a leader in supporting pharmaceutical innovation”
Robert P. Mauch, President and Chief Executive Officer of Cencora
“The updated reporting structure will also give our shareholders a clearer view of our progress against our strategic priorities and how we are creating sustainable, long-term value across our enterprise.”
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
Cencora, Inc. (NYSE: COR) today announced that it is realigning its corporate and reporting structure to strengthen execution and visibility.
Get started
Create a free account to read the full story.